Two new articles make a case for maintaining current US Nuclear Regulatory Commission regulations on the release of patients who undergo radioactive iodine treatments for thyroid cancer, known as I-131.
Two new articles make a case for maintaining current US Nuclear Regulatory Commission regulations on the release of patients who undergo radioactive iodine treatments for thyroid cancer, known as I-131.